Evaluation of treatment responses in late Lyme borreliosis on the basis of antibody decrease during the follow-up period

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 9, 1999, Pages 621-629

  Panelius, J ^a   Seppala I ^a   Granlund, H ^b   Nyman, D ^b   Wahlberg, P ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Aland Central Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFADROXIL; CEFTRIAXONE; DOXYCYCLINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PENICILLIN G; PROBENECID;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; FLAGELLUM; FOLLOW UP; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032710403     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050362     Document Type: Article

References (38)

1. 1. Sigal LH: Pitfalls in the diagnosis and management of Lyme disease. Arthritis and Rheumatism (1998) 41:195-204
2. 2. Hauser U, Krahl H, Peters H, Fingerle V, Wilske B: Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. Journal of Clinical Microbiology (1998) 36:427-436
3. 3. Hammers-Berggren S, Lebech A-M, Karlsson M, Andersson U, Hansen K, Stiernstedt G: Serological follow-up after treatment of borrelia arthritis and acrodermatitis chronica atrophicans. Scandinavian Journal of Infectious Diseases (1994) 26:339-347
4. 4. Craft JE, Grodzicki R, Steere AC: Antibody response in Lyme disease: evaluation of diagnostic tests. Journal of Infectious Diseases (1984) 149:789-795
5. 5. Feder HM Jr, Gerber MA, Luger SW, Ryan RW: Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clinical Infectious Diseases (1992) 15:788-793
6. 6. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppälä I: Treatment of late Lyme borreliosis. Journal of Infection (1994) 29:255-261
7. 7. Hammers-Berggren S, Lebech A-M, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G: Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. Journal of Clinical Microbiology (1994) 32:1519-1525
8. 8. Olsson I, Hammarström L, Smith CIE, Hovmark A, Åsbrink E: IgG subclasses of specific antibodies in ixodes ricinusborne borreliosis. Clinical and Experimental Immunology (1987) 69:618-623
9. 9. Seppälä IJT, Kroneld R, Schauman K, Forsen K-O, Lassenius R: Diagnosis of Lyme borreliosis: non-specific serological reactions with Borrelia burgdorferi sonicate antigen caused by IgG2 antibodies. Journal of Medical Microbiology (1994) 40:293-302
10. 10. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppälä I: Late Lyme borreliosis: epidemiology, diagnosis and clinical features. Annals of Medicine (1993) 25:349-352
11. 11. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW: Case definitions for public health surveillance. Morbidity & Mortality Weekly Report (1990) 39 (RR-13): 19-21
12. 12. Carlsson S-A, Granlund H, Nyman D, Wahlberg P: IgG seroprevalence of Lyme borreliosis in the population of the Åland Islands in Finland. Scandinavian Journal of Infectious Diseases (1998) 30:501-503
13. 13. Sarnesto A: Monoclonal antibodies reacting with isotypic and/or allotypic determinants of human IgG. Medical Biology (1983) 61:126-132
14. 14. Seppälä I, Sarvas H, Mäkelä O, Mattila P, Eskola J, Käyhty H: Human antibody responses to two conjugate vaccines of Haemophilus influenzae, type b saccharides and diphtheria toxin. Scandinavian Journal of Immunology (1988) 28:471-479
15. 15. Hilton E, Tramontano A, De Voti J, Sood SK: Temporal study of immunoglobulin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. Journal of Clinical Microbiology (1997) 35:774-776
16. 16. Horowitz HW, Pavia CS, Bittker S, Forseter G, Cooper D, Nadelman RB, Byrne D, Johnson RC, Wormser GP: Sustained cellular immune responses to Borrelia burgdorferi: lack of correlation with clinical presentation and serology. Clinical Diagnostics and Laboratory Immunology (1994) 1:373-378
17. 17. Krause A, Brade V, Schoerner C, Solbach W, Kalden JR, Burmester GR: T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation. Arthritis and Rheumatism (1991) 34:393-402
18. 18. Karlsson M: Aspects of the diagnosis of Lyme borreliosis. Scandinavian Journal of Infectious Diseases (1990) 22, Supplement 67:1-59
19. 19. Roberg M, Forsberg P, Fryden A, Hederstedt B, Hyden D, Ödkvist L: Long-term findings in patients with facial palsy and antibodies against Borrelia burgdorferi. Scandinavian Journal of Infectious Diseases (1994) 26:559-567
20. 20. Fuchs R, Wilske B, Preac-Mursic V, Schierz G: Purification of the Borrelia burgdorferi flagellum by use of a monoclonal antibody. Molecular and Cellular Probes (1990) 4:451-462
21. 21. Hansen K, Åsbrink E: Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. Journal of Clinical Microbiology (1989) 27:545-551
22. 22. Grodzicki RL, Steere AC: Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. Journal of Infectious Diseases (1988) 157:790-797
23. 23. Coleman JL, Benach JL: Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis. Journal of Infectious Diseases (1987) 155:756-765
24. 24. Karlsson M, Stiernstedt G, Granström M, Åsbrink E, Wretlind B: Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis. European Journal of Clinical Microbiology & Infectious Diseases (1990) 9:169-177
25. 25. Brunner M, Stein S, Mitchell PD, Sigal LH: Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope. Journal of Clinical Microbiology (1998) 36:1074-1080
26. 26. Johnson BJB, Robbins KE, Bailey RE, Cao B-L, Sviat SL, Craven RB, Mayer LW, Dennis DT: Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. Journal of Infectious Diseases (1996) 174:346-353
27. 27. Barbour AG, Grunwaldt E, Steere C: Antibodies of patients with Lyme disease to components of the Ixodes dammini spirochete. Journal of Clinical Investigation (1983) 72:504-515
28. 28. Kaiser R, Rasiah C, Gassmann G, Vogt A, Lucking CH: Intrathecal antibody synthesis in Lyme neuroborreliosis: use of recombinant p41 and 14-kDa flagellin fragment in ELISA. Journal of Medical Microbiology (1993) 39:290-297
29. 29. Namba K, Yamashita I, Vonderviszt F: Structure of the core and central channel of bacterial flagella. Nature (1989) 342:648-654
30. 30. Feldmann M: Immunogenicity in vitro: structural correlation. In : Ada GL (ed): Contemporary topics in molecular immunology. Plenum Press, New York (1974) p 57
31. 31. Artsorb H, Huibner S: Complement fixation test for the diagnosis of Lyme disease. Journal of Clinical Microbiology (1990) 28:637-638
32. 32. Hechemy KE, Harris HL, Duerr MJ, Benach JL, Reimer CB: Immunoglobulin G subclasses specific to Borrelia burgdorferi in patients with Lyme disease. Annals of the New York Academy of Sciences (1988) 539:162-169
33. 33. Hedman K, Seppälä I: Recent rubella virus infection indicated by a low avidity of specific IgG. Journal of Clinical Immunology (1988) 8:214-221
34. 34. Asano Y, Hiroishi Y, Itakura N, Hirose S, Kajita Y, Nagai T, Yazaki T, Takahashi M: Immunoglobulin subclass antibodies to varicella zoster virus. Pediatrics (1987) 80:933-936
35. 35. Ljungman P, Zetterqvist L, Sundqvist V-A, Jeansson S, Heimdahl A, Wahren B: Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations. Clinical and Experimental Immunology (1988) 72:207-210
36. 36. Franssila R, Söderlund M, Brown C, Spaan W, Seppälä I, Hedman K: IgG subclass response to human parvovirus B19 infection. Clinical and Diagnostic Virology (1996) 6:41-49
37. 37. Linde GA: Subclass distribution of rubella virus-specific immunoglobulin G. Journal of Clinical Microbiology (1985) 21:117-121
38. 38. Fahrer H, Sauvain MJ, Zhioua E, Van Hoecke C, Gern LE: Longterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals? European Journal of Epidemiology (1998) 14:117-123